ESG, EIA and OECD NCP proceedings – comprehensive defence of an industrial plant during production expansion

Client: automotive components manufacturer | 

The situation

An industrial components manufacturer was planning to expand its production facility in Poland. The investment, formally compliant with all regulations  faced public opposition from groups alleging violations of air emission standards. The case was exceptional in combining three distinct risk fronts: administrative and court proceedings on the EIA, environmental compliance allegations, and, rarely seen on the Polish market, proceedings before the OECD National Contact Point (NCP) initiated by an NGO.

Our role

We represented the client in all administrative and court proceedings, refuting allegations of emission standard violations and demonstrating full compliance with Polish and EU environmental law. We advise on integrating the ESG strategy with a compliance framework aligned with the OECD Guidelines. We support the client in the NCP proceedings at both the initial assessment stage and subsequent mediation.

The result

The matter is one of the first in Poland in which an ESG strategy, EIA proceedings and the OECD NCP mechanism are combined within a single advisory project. It clearly illustrates the new risk landscape for industrial investors: today, meeting formal requirements is no longer enough — active management of reputation and relationships with all stakeholders is essential.

Does your investment combine environmental, social and ESG risk? We can help manage it comprehensively.

Security of the investment process

Many investments are not stopped by regulations – they are stopped by public protests, the actions of environmental organisations, prolonged proceedings, and risks that were not properly managed. We advise investors at every stage of the investment process, from the first decision through to effective defence before the courts in any disputes that may arise.

More

They may be interested you

I want to obtain biological material for research purposes, should I consider the Convention on Biological Diversity and the Nagoya Protocol?

Client Global chemicals and Life Sciences group The situation The Convention on Biological Diversity and the Nagoya Protocol on access to genetic r...

Case study Product law

I want to obtain biological material for research purposes, should I consider the Convention on Biological Diversity and the Nagoya Protocol?

Trade Inspection is challenging my product compliance- how do I defend myself in proceedings and limit my risk?

Client Operator of a discount store chain with a wide non-food assortment The situation Growing EU regulatory requirements on product safety, label...

Case study Product law

Trade Inspection is challenging my product compliance- how do I defend myself in proceedings and limit my risk?

The EU plans to ban PFAS in my products under REACH – how do I build an advocacy strategy and secure an exemption or transition period?

Client Global manufacturer in the technology and industrial sector The situation The pan-European REACH restriction proposal on PFAS covering all n...

Case study Product law

The EU plans to ban PFAS in my products under REACH – how do I build an advocacy strategy and secure an exemption or transition period?

See all

Do you need legal support for an investment or product?

Write or call – we'll answer you specifically
and without unnecessary theory.